Highbridge Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,700
Closed -$204K 1337
2017
Q4
$204K Buy
+6,700
New +$178K ﹤0.01% 1502
2017
Q3
Sell
-326,384
Closed -$8.04M 1600
2017
Q2
$8.04M Buy
326,384
+117,860
+57% +$2.49M 0.12% 212
2017
Q1
$4.52M Buy
208,524
+193,301
+1,270% +$3.93M 0.07% 315
2016
Q4
$227K Buy
+15,223
New +$220K ﹤0.01% 1073
2014
Q3
Sell
-34,577
Closed -$117K 1245
2014
Q2
$117K Buy
+34,577
New +$119K ﹤0.01% 1001

Other funds holding EXEL

Highbridge Capital Management's EXEL Position: Q1 2018 in Review

Highbridge Capital Management sold out of Exelixis (EXEL) in Q1 2018, closing a stake of 6,700 shares — an estimated $204K sold.

Highbridge Capital Management first reported a position in EXEL in Q2 2014 and held it in 5 quarters. The position peaked at $8.04M in Q2 2017. 294 funds tracked by Wall St. Rank hold EXEL as of Q1 2018.

  • Highbridge Capital Management reported no remaining Exelixis position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 6,700 Exelixis shares in Q1 2018, an estimated $204K.
  • Highbridge Capital Management first reported a position in Exelixis in Q2 2014 and held it in 5 quarters.
  • Highbridge Capital Management's Exelixis position peaked at $8.04M in Q2 2017.
  • 294 funds tracked by Wall St. Rank held Exelixis as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.